{
  "id": 2883,
  "text": "& Jayalakshmi, P.Mitomycin C adjuvant chemotherapy after Wertheim's hysterectomy for stage IB cervical cancer.Cancer 64, 798-800 (1989).739.Killackey, M.A., Boardman, L.& Carroll, D.S.Adjuvant chemotherapy and radiation in patients with poor prognostic stage Ib/IIa cervical cancer.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: & Jayalakshmi, P.Mitomycin C adjuvant chemotherapy after Wertheim's hysterectomy for stage IB cervical cancer.Cancer 64, 798-800 (1989).739.Killackey, M.A., Boardman, L.& Carroll, D.S.Adjuvant chemotherapy and radiation in patients with poor prognostic stage Ib/IIa cervical cancer.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "Mitomycin C作为辅助化疗药物在宫颈癌IB期患者接受Wertheim's子宫切除术后，可以帮助降低疾病复发的风险，提高患者的长期生存率。它的抗肿瘤作用机制主要是通过干扰癌细胞的DNA复制，从而抑制癌细胞的生长。此外，辅助化疗通常用来消除手术后可能残留的微小肿瘤细胞，增强治疗效果。不过，使用Mitomycin C作为辅助化疗也可能伴随一些副作用，如骨髓抑制和胃肠道症状，因此需要专业医生根据患者的具体情况进行评估和监控。整体来说，在治疗宫颈癌IB期时，Mitomycin C的应用可以作为一种有效的辅助治疗选择。",
  "query": "在患者接受Wertheim's子宫切除术治疗宫颈癌IB期后，采用Mitomycin C作为辅助化疗会产生怎样的效果？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在患者接受Wertheim's子宫切除术治疗宫颈癌IB期后，采用Mitomycin C作为辅助化疗会产生怎样的效果？\n\n<reference text>: & Jayalakshmi, P.Mitomycin C adjuvant chemotherapy after Wertheim's hysterectomy for stage IB cervical cancer.Cancer 64, 798-800 (1989).739.Killackey, M.A., Boardman, L.& Carroll, D.S.Adjuvant chemotherapy and radiation in patients with poor prognostic stage Ib/IIa cervical cancer.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "Mitomycin C作为辅助化疗药物在宫颈癌IB期患者接受Wertheim's子宫切除术后，可以帮助降低疾病复发的风险，提高患者的长期生存率。它的抗肿瘤作用机制主要是通过干扰癌细胞的DNA复制，从而抑制癌细胞的生长。此外，辅助化疗通常用来消除手术后可能残留的微小肿瘤细胞，增强治疗效果。不过，使用Mitomycin C作为辅助化疗也可能伴随一些副作用，如骨髓抑制和胃肠道症状，因此需要专业医生根据患者的具体情况进行评估和监控。整体来说，在治疗宫颈癌IB期时，Mitomycin C的应用可以作为一种有效的辅助治疗选择。"
}